Physician profile
Anna Rees
NPI 1114550662
$6,016.15
in general payments reported to CMS, 2019-2025
19 companies · $113 in 2025
The $113 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,049 · 2022: $2,743 · 2023: $667 · 2024: $444 · 2025: $113.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,224.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,223.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pylant Medical | $4,197.13 | 2021-2025 | |
| Arthrex, INC. | $434.00 | 2021 | |
| Smith+Nephew, INC. | $231.66 | 2023-2024 | Trigen Intertan, Evos |
| Sanara Medtech INC. | $195.37 | 2021-2024 | Celleraterx |
| Davol INC. | $137.70 | 2024 | Arista Ah Flexitip |
| Orthofix Medical, INC. | $119.95 | 2022-2024 | Physio-Stim |
| Stryker Corporation | $115.58 | 2023 | T2 Alpha, Gamma |
| Depuy Synthes Sales INC. | $98.00 | 2021 | |
| Globus Medical, INC. | $86.71 | 2023 | Distal Femur Plate System, Proximal Humerus Strut |
| Si-Bone, INC. | $82.65 | 2022-2024 | |
| Medical Device Business Services, INC. | $61.70 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $51.87 | 2025 | |
| Kerecis Limited | $51.51 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Kowa Pharmaceuticals America, INC. | $34.69 | 2023 | Seglentis |
| Xtant Medical INC | $30.04 | 2023 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $26.40 | 2025 | Durolane |
| Kci USA, INC. | $21.38 | 2022 | |
| Ferring Pharmaceuticals INC. | $20.16 | 2025 | Euflexxa |
| Pacira Pharmaceuticals Incorporated | $19.65 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Rees listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.